FDA.reportPublic FDA data

bendamustine Injectable Solution [Bendeka]

RxCUI
1726100
RxNorm name
bendamustine Injectable Solution [Bendeka]
Term type
SBDF
Status
Active
Updated
2026-10-21 00:30:43

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
012016
Active start
012016
Multiple ingredient
NO
Branded
YES

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Injectable Solution316949

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
bendamustine134547

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRbendamustine Injectable Solution [Bendeka]1NAMES
RxNorm Namebendamustine Injectable Solution [Bendeka]1NAMES
TTYSBDF1ATTRIBUTES
RxCUI17261001CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCL01AANitrogen mustard analoguesATC1-4bendamustine
FDASPLN0000175558Alkylating DrugEPChas_epcbendamustine
FDASPLN0000000236Alkylating ActivityMOAhas_moabendamustine
MEDRTD000069461Bendamustine HydrochlorideCHEMhas_ingredientbendamustine hydrochloride
MEDRTD000069461Bendamustine HydrochlorideCHEMhas_ingredientbendamustine
MEDRTD004342Drug HypersensitivityDISEASEci_withbendamustine hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withbendamustine
MEDRTD007945Leukemia, LymphoidDISEASEmay_treatbendamustine hydrochloride
MEDRTD007945Leukemia, LymphoidDISEASEmay_treatbendamustine
MEDRTD008228Lymphoma, Non-HodgkinDISEASEmay_treatbendamustine hydrochloride
MEDRTD008228Lymphoma, Non-HodgkinDISEASEmay_treatbendamustine
MEDRTN0000000236Alkylating ActivityMOAhas_moabendamustine hydrochloride
MEDRTN0000000236Alkylating ActivityMOAhas_moabendamustine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESRXNAV_HUMAN_DRUGUS